
ABOUT US
Inventing novel and innovative molecular medicines for treatment of cardiorenal, pulmonary, fibrotic, neuroendocrine and neurodegenerative diseases and psychiatric disorders.
INVENT Pharmaceuticals is designing, inventing and developing new safer and highly effective medicines to help improve patients lives.
We design, discover and develop new medicines by applying out powerful precision drug design and discovery platform. INVENT Pharmaceuticals integrates its innovative drug design with medicinal chemistry and drug discovery, site specific precision molecular modification, in vitro and in vivo pharmacology, and deep domain knowledge and expertise, capabilities and artificial intelligence.

Therapeutic Areas
Cardiovascular-Renal-Pulmonary-Metabolic (CvRPM)
Cardiopulmonary - Pulmonary Arterial Hypertension (PAH)
Cardiorenal - Chronic Kidney Disease (CKD)
Uncontrolled/Resistance Hypertension (u/rHTN)
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
CNS Diseases and Disorders
Small-intestine Neuroendocrine Tumors (Si-NET)
Liver Fibrosis
Pulmonary Fibrosis
Cancer/Fibrotic Diseases
Alzheimer's Disease
Cognitive Impairment Associated with Schizophrenia
Central Nervous System (CNS) Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Post-traumatic Stress Disorder (PTSD)
Major Depressive Disorder (MDD)
Geneeral Anxiety Disorder (GAD)

Our Commitment
We are committed to advancing transformative therapeutics through the integration of precision science, cutting-edge technology, and deep therapeutic expertise.
info@inventpharma.com


© 2026 INVENT Pharmaceuticals. All rights reserved.
